Immunological factors in cirrhosis diseases from a bibliometric point of view

Table 5 Top 10 co-cited references on research of immunological factors in cirrhosis

Rank	Reference	Year	Journal	Citation	Centrality
1	Mechanisms of hepatic stellate cell activation	2017	Nature Reviews Gastroenterology & Hepatology	50	0.03
2	Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance	2014	Journal of Hepatology	46	0.02
3	EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection	2017	Journal of Hepatology	35	0.03
4	Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis	2013	Gastroenterology	35	0.03
5	Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries	2018	CA: A Cancer Journal for Clinicians	33	0.02
6	Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): An open-label, non-comparative, phase 1/2 dose escalation and expansion trial	2017	Lancet	33	0.04
7	Immunology in the liver-from homeostasis to disease	2016	Nature Reviews Gastroenterology & Hepatology	32	0.14
8	Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure	2016	Hepatology	31	0.07
9	Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants	2009	The New England Journal of Medicine	31	0.02
10	TLR4 enhances TGF-beta signaling and hepatic fibrosis	2007	Nature Medicine	31	0.06